Papers/PMID:17636753
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.
The Cochrane database of systematic reviews2007The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
L-arginine — decreases necrotising enterocolitis incidence
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“There was a statistically significant reduction in the risk of developing NEC (any stage) in the arginine group compared with the placebo group [RR 0.24 (95% CI 0.10, 0.61), RD -0.21 (95% CI -0.32, -0.09)].”
Quoted verbatim from Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.. - Study
- meta-analysis
- Population
- preterm neonates given enteral or parenteral arginine supplementation vs placebo or no treatment, pooled from the single eligible trial identified by this review
Effect 0.24 risk ratio, 95% CI 0.1 to 0.61
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.2007PMID:17636753Permalink